TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway
Dengfeng Wang1, Jenny Nga Ting Fung, Ya Tuo
1Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu, PR China.
Abstract:
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factor-inducible immediate-early response protein 14 (Fn14) have been detected in several human tumors, and demonstrated to regulate multiple cellular responses, including proliferation, survival, migration, apoptosis and differentiation, suggesting roles in cancer. The objective of this study was to clarify the role of TWEAK/Fn14 in the development of human endometrial cancer. We found that TWEAK gene expression was down-regulated and Fn14 gene expression was up-regulated in human endometrial cancer specimens compared with that in normal endometrial specimens; TWEAK acting on Fn14 decreased cell viability by inducing apoptosis through caspase pathways in endometrial cancer cells. Our results suggest that Fn14 expression is high in endometrial cancers whereas local produced TWEAK may be low. TWEAK/Fn14 pathway activation may promote cancer cell apoptosis, which provides a new therapeutic target for human endometrial cancer treatment.
Insights
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) signaling via its receptor Fn14 promotes apoptosis in endometrial cancer cells. This pathway, with high Fn14 and low TWEAK, presents a novel therapeutic target for endometrial cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- The TWEAK/Fn14 pathway is implicated in various human tumors.
- This pathway regulates critical cellular functions like proliferation, survival, migration, apoptosis, and differentiation.
- Its specific role in endometrial cancer development requires elucidation.
Purpose of the Study:
- To investigate the role of the TWEAK/Fn14 pathway in human endometrial cancer development.
- To analyze TWEAK and Fn14 expression levels in endometrial cancer tissues.
Main Methods:
- Gene expression analysis of TWEAK and Fn14 in human endometrial cancer and normal tissues.
- Assessment of TWEAK's effect on endometrial cancer cell viability and apoptosis induction.
- Investigation of caspase pathway involvement in TWEAK-induced apoptosis.
Main Results:
- TWEAK gene expression was significantly down-regulated in endometrial cancer specimens.
- Fn14 gene expression was significantly up-regulated in endometrial cancer specimens.
- TWEAK treatment induced apoptosis and decreased cell viability in endometrial cancer cells via caspase pathways.
Conclusions:
- Endometrial cancers exhibit high Fn14 expression and potentially low local TWEAK production.
- Activation of the TWEAK/Fn14 pathway promotes cancer cell apoptosis.
- The TWEAK/Fn14 pathway represents a potential therapeutic target for human endometrial cancer.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Caspases
Cellular Injury V: Apoptosis and Autophagy
Apoptosis

